Natixis’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.1M | Buy |
43,359
+10,056
| +30% | +$2.53M | 0.03% | 321 |
|
|
2025
Q4 | $9.47M | Buy |
33,303
+7,028
| +27% | +$2.2M | 0.03% | 340 |
|
|
2025
Q3 | $8.11M | Sell |
26,275
-1,288
| -5% | -$404K | 0.04% | 338 |
|
|
2025
Q2 | $8.66M | Buy |
+27,563
| New | +$7.96M | 0.04% | 260 |
|
|
2024
Q3 | – | Sell |
-13,079
| Closed | -$2.64M | – | 1082 |
|
|
2024
Q2 | $2.64M | Sell |
13,079
-7,985
| -38% | -$1.44M | 0.02% | 371 |
|
|
2024
Q1 | $3.61M | Buy |
+21,064
| New | +$3.93M | 0.02% | 349 |
|
|
2023
Q4 | – | Sell |
-16,356
| Closed | -$2.61M | – | 1145 |
|
|
2023
Q3 | $2.61M | Buy |
16,356
+8,196
| +100% | +$1.84M | 0.02% | 366 |
|
|
2023
Q2 | $2.35M | Buy |
+8,160
| New | +$2.48M | 0.02% | 401 |
|
|
2022
Q4 | – | Sell |
-10,097
| Closed | -$2.39M | – | 1296 |
|
|
2022
Q3 | $2.39M | Buy |
10,097
+1,520
| +18% | +$381K | 0.01% | 565 |
|
|
2022
Q2 | $1.87M | Sell |
8,577
-8,974
| -51% | -$2.04M | 0.01% | 675 |
|
|
2022
Q1 | $4.67M | Sell |
17,551
-3,120
| -15% | -$766K | 0.02% | 563 |
|
|
2021
Q4 | $5.5M | Sell |
20,671
-4,688
| -18% | -$1.36M | 0.02% | 536 |
|
|
2021
Q3 | $7.21M | Buy |
25,359
+5,101
| +25% | +$1.45M | 0.02% | 441 |
|
|
2021
Q2 | $5.56M | Sell |
20,258
-146,824
| -88% | -$39.9M | 0.02% | 361 |
|
|
2021
Q1 | $43.6M | Buy |
167,082
+101,895
| +156% | +$27.3M | 0.14% | 147 |
|
|
2020
Q4 | $16.7M | Buy |
65,187
+43,236
| +197% | +$10.7M | 0.06% | 292 |
|
|
2020
Q3 | $5.19M | Sell |
21,951
-6,060
| -22% | -$1.28M | 0.04% | 270 |
|
|
2020
Q2 | $5.44M | Buy |
28,011
+8,505
| +44% | +$1.63M | 0.04% | 273 |
|
|
2020
Q1 | $3.23M | Sell |
19,506
-37,795
| -66% | -$6.91M | 0.03% | 322 |
|
|
2019
Q4 | $9.7M | Buy |
+57,301
| New | +$9.55M | 0.06% | 288 |
|
|
2019
Q1 | – | Sell |
-59,680
| Closed | -$4.73M | – | 867 |
|
|
2018
Q4 | $4.73M | Buy |
59,680
+2,390
| +4% | +$202K | 0.04% | 329 |
|
|
2018
Q3 | $6.07M | Sell |
57,290
-64,346
| -53% | -$6.02M | 0.04% | 351 |
|
|
2018
Q2 | $10.4M | Buy |
121,636
+7,944
| +7% | +$712K | 0.06% | 284 |
|
|
2018
Q1 | $9.86M | Buy |
113,692
+43,173
| +61% | +$3.35M | 0.06% | 254 |
|
|
2017
Q4 | $4.87M | Buy |
70,519
+31,671
| +82% | +$2.08M | 0.04% | 301 |
|
|
2017
Q3 | $2.14M | Buy |
38,848
+27,017
| +228% | +$1.48M | 0.02% | 401 |
|
|
2017
Q2 | $607K | Buy |
11,831
+1,433
| +14% | +$62.2K | 0.01% | 483 |
|
|
2017
Q1 | $448K | Buy |
+10,398
| New | +$446K | 0.01% | 543 |
|
Other funds holding PODD
VCM
VPM
Natixis's PODD Position: Q1 2026 in Review
Natixis increased its Insulet (PODD) stake by 30% in Q1 2026, buying an estimated $2.53M and bringing the position to 43,359 shares worth $9.1M. The position accounts for 0.03% of the portfolio, ranked #321.
Natixis first reported a position in PODD in Q1 2017 and has held it in 28 quarters since. The position peaked at $43.6M in Q1 2021. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.
- Natixis held 43,359 shares of Insulet worth $9.1M as of Q1 2026.
- Natixis bought 10,056 Insulet shares in Q1 2026, an estimated $2.53M.
- Insulet made up 0.03% of Natixis's portfolio in Q1 2026, its #321 holding.
- Natixis first reported a position in Insulet in Q1 2017 and has held it in 28 quarters since.
- Natixis's Insulet position peaked at $43.6M in Q1 2021.
- 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.